One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Pharmacy Access to Sterile Injection Supplies for People Who Inject Drugs
Brian S. Barnett, MD; Nathaniel P. Morris, MD
doi : 10.1001/jamainternmed.2020.6840
2021;181(2):153-154
Cultural Barriers to Help-Seeking in Medical Education
Erene Stergiopoulos, MD, MA; Ligia Fragoso, MA; Lisa M. Meeks, PhD
doi : 10.1001/jamainternmed.2020.7567
2021;181(2):155-156
A Nursing Researcher’s Experience in a COVID-19 Vaccine Trial
Kristen R. Choi, PhD, RN
doi : 10.1001/jamainternmed.2020.7087
2021;181(2):157-158
Eastern Kentucky’s Lost Generation and the Echoes That Remain—The Aftermath of the Opioid Epidemic
Brian S. Barnett, MD
doi : 10.1001/jamainternmed.2020.7383
2021;181(2):158-159
Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018
Patrick C. DeMartino, MD; Milo? D. Miljkovi?, MD, MSc; Vinay Prasad, MD, MPH
doi : 10.1001/jamainternmed.2020.5921
2021;181(2):162-167
The growth of cancer drug spending in the US has outpaced spending in nearly all other sectors, and an increasing proportion of the drug development pipeline is devoted to oncology. In 2018, there was a record number of drugs entering the US market.
Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic HyperglycemiaA Randomized Clinical Trial
Michael Sampson, MD; Allan Clark, PhD; Max Bachmann, PhD; et al.
doi : 10.1001/jamainternmed.2020.5938
2021;181(2):168-178
Nearly half of the older adult population has diabetes or a high-risk intermediate glycemic category, but we still lack trial evidence for effective type 2 diabetes prevention interventions in most of the current high-risk glycemic categories.
Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 YearsA Meta-analysis
Lindsey C. Yourman, MD; Irena S. Cenzer, MA; W. John Boscardin, PhD; et al.
doi : 10.1001/jamainternmed.2020.6084
2021;181(2):179-185
Guidelines recommend targeting preventive interventions toward older adults whose life expectancy is greater than the intervention’s time to benefit (TTB). The TTB for statin therapy is unknown.
Changes in Health Care Use and Outcomes After Turnover in Primary Care
Adrienne H. Sabety, PhD; Anupam B. Jena, MD, PhD; Michael L. Barnett, MD, MS
doi : 10.1001/jamainternmed.2020.6288
2021;181(2):186-194
Disruptions of continuity of care may harm patient outcomes, but existing studies of continuity disruption are limited by an inability to separate the association of continuity disruption from that of other physician-related factors.
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial
Benjamin S. Abella, MD, MPhil; Eliana L. Jolkovsky, BA; Barbara T. Biney, MPH; et al.
doi : 10.1001/jamainternmed.2020.6319
2021;181(2):195-202
Health care workers (HCWs) caring for patients with coronavirus disease 2019 (COVID-19) are at risk of exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, to our knowledge, there is no effective pharmacologic prophylaxis for individuals at risk.
Association of Physical Activity Intensity With Mortal ityA National Cohort Study of 403?681 US Adults
Yafeng Wang, MSc; Jing Nie, BSc; Gerson Ferrari, PhD; et al.
doi : 10.1001/jamainternmed.2020.6331
2021;181(2):203-211
It is unclear whether, for the same amount of total physical activity, a higher proportion of vigorous physical activity (VPA) to total physical activity is associated with a greater reduction in mortality.
Thematic Analysis of the Health Records of a National Sample of US Veterans With Advanced Kidney Disease Evaluated for Transplant
Catherine R. Butler, MD, MA; Aaron Wightman, MA, MD; Claire A. Richards, RN, PhD; et al.
doi : 10.1001/jamainternmed.2020.6388
2021;181(2):212-219
To be considered for a kidney transplant, patients with advanced kidney disease must participate in a formal evaluation and selection process. Little is known about how this process proceeds in real-world clinical settings.
Financial Presentation of Alzheimer Disease and Related Dementias
Lauren Hersch Nicholas, PhD, MPP; Kenneth M. Langa, MD, PhD; Julie P. W. Bynum, MD, MPH; et al.
doi : 10.1001/jamainternmed.2020.6432
2021;181(2):220-227
Alzheimer disease and related dementias (ADRD), currently incurable neurodegenerative diseases, can threaten patients’ financial status owing to memory deficits and changes in risk perception. Deteriorating financial capabilities are among the earliest signs of cognitive decline, but the frequency and extent of adverse financial events before and after diagnosis have not been characterized.
Association Between Nursing Home Crowding and COVID-19 Infection and Mortality in Ontario, Canada
Kevin A. Brown, PhD; Aaron Jones, MSc; Nick Daneman, MD, MSc; et al.
doi : 10.1001/jamainternmed.2020.6466
2021;181(2):229-236
Nursing home residents have been disproportionately affected by coronavirus disease 2019 (COVID-19). Prevention recommendations emphasize frequent testing of health care personnel and residents, but additional strategies are needed.
Epidemiologic Trends in Fatal and Nonfatal Firearm Injuries in the US, 2009-2017
Elinore J. Kaufman, MD, MSHP; Douglas J. Wiebe, PhD; Ruiying Aria Xiong, MS; et al.
doi : 10.1001/jamainternmed.2020.6696
2021;181(2):237-244
Firearm injury research in the US has focused on fatal injuries. The incidence and epidemiologic factors associated with nonfatal firearm injuries are less understood.
Euthanasia and Physician-Assisted Suicide in Patients With Multiple Geriatric Syndromes
Vera van den Berg, MA; Ghislaine van Thiel, PhD; Margot Zomers, MSc; et al.
doi : 10.1001/jamainternmed.2020.6895
2021;181(2):245-250
The Dutch Regional Euthanasia Review Committees (RTEs) reviewed and reported an increasing number of cases of euthanasia and physician-assisted suicide (EAS) requested by older people with multiple geriatric syndromes (MGS). Knowledge of the characteristics of cases of EAS for MGS is important to facilitate societal debate and to monitor EAS practice.
The Treatment of Patients With Unbearable Suffering—The Slippery Slope Is Real
Diane E. Meier, MD
doi : 10.1001/jamainternmed.2020.6884
2021;181(2):160-161
no abstract
Assessment of Electronic Health Record Use Between US and Non-US Health Systems
A. Jay Holmgren, MHI; N. Lance Downing, MD; David W. Bates, MD, MSc; et al.
doi : 10.1001/jamainternmed.2020.7071
2021;181(2):251-259.
Understanding how the electronic health record (EHR) system changes clinician work, productivity, and well-being is critical. Little is known regarding global variation in patterns of use.
Desktop Medicine and the Practice of Wealth Care
Jason Karlawish, MD
doi : 10.1001/jamainternmed.2020.6441
2021;181(2):227-228
Advancing Practice Science With Electronic Health Record Use Data
Christine Sinsky, MD
doi : 10.1001/jamainternmed.2020.7068
2021;181(2):260-261
Caution in Prescribing Modafinil and Armodafinil to Individuals Who Could Become Pregnant
Neda Ghaffari, MD; Patricia A. Robertson, MD
doi : 10.1001/jamainternmed.2020.4206
2021;181(2):277-278
Outcomes of Cardiopulmonary Resuscitation in Patients With COVID-19—Limited Data, but Further Reason for Action
Matthew E. Modes, MD, MPP, MS; Robert Y. Lee, MD, MS; J. Randall Curtis, MD, MPH
doi : 10.1001/jamainternmed.2020.4779
2021;181(2):281-282
The Colchicine Debacle Revisited
B. Joseph Guglielmo, PharmD
doi : 10.1001/jamainternmed.2020.5044
2021;181(2):287-288
Deferral of Care for Serious Non–COVID-19 ConditionsA Hidden Harm of COVID-19
Colette DeJong, MD; Mitchell H. Katz, MD; Kenneth Covinsky, MD
doi : 10.1001/jamainternmed.2020.4016
2021;181(2):274
Sex-Based Differences Entangling With Electronic Health Record Documentation
Jennifer Claytor, MD, MS; Richard W. Grant, MD, MPH
doi : 10.1001/jamainternmed.2020.5008
2021;181(2):290-291
Assessment of Sales and Marketing of Online Vouchers for Discounted Direct-to-Consumer Medical Imaging Services
Sheena Desai, BS; Priya Manjaly, BA; Karen Lee, BS; et al.
doi : 10.1001/jamainternmed.2020.3529
2021;181(2):267-269
Hospitalizations for Chronic Disease and Acute Conditions in the Time of COVID-19
Saul Blecker, MD, MHS; Simon A. Jones, PhD; Christopher M. Petrilli, MD; et al.
doi : 10.1001/jamainternmed.2020.3978
2021;181(2):269-271
Hospital Volumes of 5 Medical Emergencies in the COVID-19 Pandemic in 2 US Medical Centers
Hriday P. Bhambhvani, BS; Adrian J. Rodrigues, BA; Jonathan S. Yu, BS; et al.
doi : 10.1001/jamainternmed.2020.3982
2021;181(2):272-274
Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy
Sigal Kaplan, PhD, BPharm; Debra L. Braverman, MD; Ilana Frishman, MSc; et al.
doi : 10.1001/jamainternmed.2020.4009
2021;181(2):275-277
Family Caregiving for Those With and Without Dementia in the Last 10 Years of Life
Jennifer M. Reckrey, MD; Evan Bollens-Lund, MA; Mohammed Husain, MA; et al.
doi : 10.1001/jamainternmed.2020.4012
2021;181(2):278-279
Clinical Outcomes of In-Hospital Cardiac Arrest in COVID-19
Shrinjaya B. Thapa, MD; Tanya S. Kakar, MD; Corey Mayer, DO, MBA; et al.
doi : 10.1001/jamainternmed.2020.4796
2021;181(2):279-281
Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019
Marissa H. Elliott, MPH; Joshua J. Skydel, BS; Sanket S. Dhruva, MD, MHS; et al.
doi : 10.1001/jamainternmed.2020.4799
2021;181(2):282-284
Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine
Natalie McCormick, PhD; Zachary S. Wallace, MD, MSc; Chio Yokose, MD; et al.
doi : 10.1001/jamainternmed.2020.5017
2021;181(2):284-287
Electronic Health Record Use by Sex Among Physicians in an Academic Health Care System
Sarah D. Tait, BA; Sachiko M. Oshima, BA; Yi Ren, MS; et al.
doi : 10.1001/jamainternmed.2020.5036
2021;181(2):288-290
Ventricular Preexcitation in a Patient Found to Have Wolff-Parkinson-White Pattern
Anjali B. Thakkar, MD, MBA; Melvin Scheinman, MD; Nora Goldschlager, MD
doi : 10.1001/jamainternmed.2020.6847
2021;181(2):262-263
An Elderly Woman With a Pause—Never Miss a Beat
Ahlam A. Al Awadhi, MBBS; Omar Al Falasi, MBBS, MD; Moutaz El Kadri, MD, MSc, PhD
doi : 10.1001/jamainternmed.2020.7064
2021;181(2):264-265
Employee Wellness Programs
Lawrence W. Raymond, MD, ScM
doi : 10.1001/jamainternmed.2020.5737
2021;181(2):291
Employee Wellness Programs
Irena Pesis-Katz, PhD; Lisa Norsen, RN, PhD; Renu Singh, MS
doi : 10.1001/jamainternmed.2020.5748
2021;181(2):291-292
Employee Wellness Programs—Reply
Julian Reif, PhD; Damon Jones, PhD; David Molitor, PhD
doi : 10.1001/jamainternmed.2020.5746
2021;181(2):292-293
Marijuana Is Not the Only Cause of Drugged Driving
Edward C. Wood, MBA
doi : 10.1001/jamainternmed.2020.6272
2021;181(2):293
Marijuana Is Not the Only Cause of Drugged Driving—Reply
Mark R. Rosekind, PhD; Johnathon P. Ehsani, PhD; Jeffrey P. Michael, EdD
doi : 10.1001/jamainternmed.2020.6275
2021;181(2):293-294
Poor Performance of Masks Secured Using Ear Loops
Chee Fu Yung, MBChB, MSt
doi : 10.1001/jamainternmed.2020.6393
2021;181(2):294
Factors Associated With the Declining Trends of Hip Fractures
Esme Fuller-Thomson, PhD; Amy P. Munro, BSc, MSW
doi : 10.1001/jamainternmed.2020.6477
2021;181(2):294-29
Factors Associated With the Declining Trends of Hip Fractures
Long Shao, MD, PhD; Xiang-Dong Wu, MD; Wei Huang, MD, PhD
doi : 10.1001/jamainternmed.2020.6480
2021;181(2):295-296
Factors Associated With the Declining Trends of Hip Fractures—Reply
Timothy Bhattacharyya, MD; Marian T. Hannan, DSc, MPH; Douglas P. Kiel, MD, MPH
doi : 10.1001/jamainternmed.2020.6474
2021;181(2):296
